 | This page is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Trilogy Evo Universal ventilator controversy; add here or ... ?
U.S taxpayers paid $13.8 million to a company to design a low-cost ventilator, but instead the company is selling it overseas.
- Patricia Callahan, Sebastian Rotella and Tim Golden Taxpayers Paid Millions to Design a Low-Cost Ventilator for a Pandemic. Instead, the Company Is Selling Versions of It Overseas. As coronavirus sweeps the globe, there is not a single Trilogy Evo Universal ventilator — developed with government funds — in the U.S. stockpile. Meanwhile, Royal Philips N.V. has sold higher-priced versions to clients around the world. March 30, 2020 Propublica.org
Related to Talk:2020 coronavirus pandemic in the United States/Archive 6#Trilogy Evo Universal ventilator; add here or ... ? X1\ ( talk) 03:32, 4 April 2020 (UTC)
| This page is an archive of past discussions. Do not edit the contents of this page. If you wish to start a new discussion or revive an old one, please do so on the current talk page. |
Trilogy Evo Universal ventilator controversy; add here or ... ?
U.S taxpayers paid $13.8 million to a company to design a low-cost ventilator, but instead the company is selling it overseas.
- Patricia Callahan, Sebastian Rotella and Tim Golden Taxpayers Paid Millions to Design a Low-Cost Ventilator for a Pandemic. Instead, the Company Is Selling Versions of It Overseas. As coronavirus sweeps the globe, there is not a single Trilogy Evo Universal ventilator — developed with government funds — in the U.S. stockpile. Meanwhile, Royal Philips N.V. has sold higher-priced versions to clients around the world. March 30, 2020 Propublica.org
Related to Talk:2020 coronavirus pandemic in the United States/Archive 6#Trilogy Evo Universal ventilator; add here or ... ? X1\ ( talk) 03:32, 4 April 2020 (UTC)